Lv4
508 积分 2023-07-11 加入
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
14天前
已完结
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
14天前
已完结
Allogeneic “Off-the-Shelf” CAR T Cells: Challenges and Advances
14天前
已完结
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
14天前
已完结
CAR-T therapy in solid tumors
16天前
已完结
In vivo manufacture and manipulation of CAR-T cells for better druggability
16天前
已完结
Direct in vivo CAR T cell engineering
16天前
已完结
Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
1个月前
已完结
Second Primary Cancer After Chimeric Antigen Receptor-T-Cell Therapy: A Review
1个月前
已完结
Transduction of Human Hematopoietic Stem Cells by Lentiviral Vectors Pseudotyped with the RD114-TR Chimeric Envelope Glycoprotein
1个月前
已完结
皖公网安备34019202002308
